Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toyoki Mori

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Endocrinology|April 16, 2005
Therapeutic effects of tolvaptan, a potent, selective nonpeptide vasopressin V2 receptor antagonist, in rats with acute and chronic severe hyponatremiaToshiki Miyazaki, Yoshitaka Yamamura, Toshiyuki Onogawa, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 16, 2007
OPC-28326, a selective femoral arterial vasodilator, augments ischemia induced angiogenesisMakoto Sumi, Masataka Sata, Ayako Hashimoto, et al.
The Journal of Medical Investigation : JMI|March 13, 2010
Correlation between salivary secretion and salivary AQP5 levels in health and diseaseDi Wang, Fusako Iwata, Masahiro Muraguchi, et al.
Journal of Pharmacological and Toxicological Methods|December 13, 2003
A method for evaluating drug effects on intermittent claudication using a treadmill in rats with unilateral hindlimb artery occlusionKensuke Orito, Masami Kishi, Hiroyuki Fujiki, et al.
Arzneimittel-Forschung|May 23, 2007
Anti-atherosclerotic effect of cilostazol in apolipoprotein-E knockout miceHiromichi Takase, Ayako Hashimoto, Reiko Okutsu, et al.
The Journal of Clinical Investigation|January 15, 2004
The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditionsAkito Tanoue, Shuji Ito, Kenji Honda, et al.
Journal of Pharmacological Sciences|April 27, 2004
Antidiuretic effects of a novel nonpeptide vasopressin V(2)-receptor agonist, OPC-51803, administered orally to dogsShigeki Nakamura, Takahiro Hirano, Toshiyuki Onogawa, et al.
Journal of Pharmacological and Toxicological Methods|July 6, 2004
A flow cytometric method for determination of the interferon receptor IFNAR2 subunit in peripheral blood leukocyte subsetsShiro Tochizawa, Seiji Akamatsu, Yoshihiro Sugiyama, et al.
Brain Research|December 4, 2003
Cilostazol reduces brain lesion induced by focal cerebral ischemia in rats--an MRI studyJeong Hyun Lee, Yong-Kyu Lee, Makoto Ishikawa, et al.
Journal of Medicinal Chemistry|June 27, 2003
Novel selective hindlimb vasodilators: synthesis and biological activity of 1-acyl-4-aminopiperidine derivativesShuji Teramoto, Michinori Tanaka, Hiroshi Shimizu, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Endocrinology|April 16, 2005
Therapeutic effects of tolvaptan, a potent, selective nonpeptide vasopressin V2 receptor antagonist, in rats with acute and chronic severe hyponatremiaToshiki Miyazaki, Yoshitaka Yamamura, Toshiyuki Onogawa, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 16, 2007
OPC-28326, a selective femoral arterial vasodilator, augments ischemia induced angiogenesisMakoto Sumi, Masataka Sata, Ayako Hashimoto, et al.
The Journal of Medical Investigation : JMI|March 13, 2010
Correlation between salivary secretion and salivary AQP5 levels in health and diseaseDi Wang, Fusako Iwata, Masahiro Muraguchi, et al.
Journal of Pharmacological and Toxicological Methods|December 13, 2003
A method for evaluating drug effects on intermittent claudication using a treadmill in rats with unilateral hindlimb artery occlusionKensuke Orito, Masami Kishi, Hiroyuki Fujiki, et al.
Arzneimittel-Forschung|May 23, 2007
Anti-atherosclerotic effect of cilostazol in apolipoprotein-E knockout miceHiromichi Takase, Ayako Hashimoto, Reiko Okutsu, et al.
The Journal of Clinical Investigation|January 15, 2004
The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditionsAkito Tanoue, Shuji Ito, Kenji Honda, et al.
Journal of Pharmacological Sciences|April 27, 2004
Antidiuretic effects of a novel nonpeptide vasopressin V(2)-receptor agonist, OPC-51803, administered orally to dogsShigeki Nakamura, Takahiro Hirano, Toshiyuki Onogawa, et al.
Journal of Pharmacological and Toxicological Methods|July 6, 2004
A flow cytometric method for determination of the interferon receptor IFNAR2 subunit in peripheral blood leukocyte subsetsShiro Tochizawa, Seiji Akamatsu, Yoshihiro Sugiyama, et al.
Brain Research|December 4, 2003
Cilostazol reduces brain lesion induced by focal cerebral ischemia in rats--an MRI studyJeong Hyun Lee, Yong-Kyu Lee, Makoto Ishikawa, et al.
Journal of Medicinal Chemistry|June 27, 2003
Novel selective hindlimb vasodilators: synthesis and biological activity of 1-acyl-4-aminopiperidine derivativesShuji Teramoto, Michinori Tanaka, Hiroshi Shimizu, et al.
Pageof 4